- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
NHLBI's Research Strategy
COVID-19 affects all of us, with the heaviest toll on those with preexisting heart, lung, and blood conditions and populations who are vulnerable to these conditions. Our research strategy aims to understand and address risk factors for the disease, develop prevention and treatment strategies, and find ways to hasten and enhance recovery.
Director's Blog
Tackling the Mysteries of the Long-term Effects of SARS-CoV-2 Infection
As we enter our second year of the devastating COVID-19 pandemic, we have learned much about the SARS-CoV-2 virus and how it can acutely affect multiple organs and systems, especially the heart, lungs, and blood vessels.
Related News
U.S. blood donations are safe under current COVID-19 screening guidelines
A new study by researchers at the National Institutes of Health and their colleagues has found that SARS-CoV-2, the virus that causes COVID-19, does not appear to pose a threat to the safety of the nation’s blood supply. The analysis, published in Transfusion , supports current donor screening guidelines, including those used by the U.S. Food and...
NIH to invest $29 million to address COVID-19 disparities
To bolster research to help communities disproportionately affected by COVID-19, the National Institutes of Health is funding $29 million in additional grants for the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities. This funding was supported by the American Rescue Plan. The awards will provide $15 million to 11 teams already...
COVID-19 and the Heart: A Bounty of Questions
In the early months of the pandemic, alarms sounded after doctors noticed that people with heart disease were faring a lot worse than others who had contracted COVID-19. Almost a year later, researchers are still pondering why these patients get sicker and die at higher rates. But they’re now puzzling over an arguably bigger mystery: why some who...
